Physician profile
Jorge Pimienta
NPI 1336200351
$2,446.69
in general payments reported to CMS, 2019-2025
18 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $218 · 2021: $550 · 2022: $407 · 2023: $675 · 2024: $219 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.36 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $561.12 | 2019-2023 | Veozah, Myrbetriq |
| Abbvie INC. | $559.08 | 2020-2024 | |
| Mission Pharmacal Company | $272.36 | 2019-2024 | Uribel, Uribel Tabs |
| Coopersurgical, INC. | $224.43 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $202.90 | 2019-2021 | |
| Evofem Biosciences, INC. | $135.54 | 2024-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $115.09 | 2024-2025 | Slynd, Tyblume |
| Allergan, INC. | $76.21 | 2019-2020 | |
| Millicent US INC | $50.99 | 2021 | |
| Avion Pharmaceuticals | $47.62 | 2021 | |
| Ascend Therapeutics US, LLC | $31.97 | 2020-2021 | |
| Becton, Dickinson and Company | $31.12 | 2022 | |
| Mayne Pharma Commercial LLC | $28.88 | 2023 | |
| Therapeuticsmd, INC. | $28.46 | 2020 | |
| Mycovia Pharmaceuticals, INC. | $26.56 | 2023 | Vivjoa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $23.29 | 2019 | |
| Hologic Sales and Service, LLC | $19.77 | 2025 | Myosure Tissue Removal Device |
| Dysis Medical, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Pimienta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.